Transcriptionally targeted nonviral gene transfer using a β-catenin/TCF-dependent promoter in a series of different human low passage colon cancer cells

Molecular Pharmaceutics

Volumn 4, Issue 1, 2007, Pages 129-139

  Gaedtke, Lars ^a   Pelisek, Jaroslav ^a   Lipinski, Kai S ^a   Wrighton, Christopher J ^a   Wagner, Ernst ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b Center of Drug Research   (Germany)

Author keywords

catenin; Colorectal cancer; Lipopolyfection; Multicellular spheroids; Nonviral gene therapy; Wnt signaling pathway

Indexed keywords

BETA CATENIN; CTP4; INTERLEUKIN 2; LIPID; LUCIFERASE; T CELL FACTOR PROTEIN; TUMOR PROMOTER; UNCLASSIFIED DRUG;

ARTICLE; COLON CANCER; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; HUMAN; HUMAN CELL; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL;

BETA CATENIN; COLONIC NEOPLASMS; CYTOMEGALOVIRUS; DNA; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; INTERLEUKIN-2; LIPIDS; LUCIFERASES; PLASMIDS; PROMOTER REGIONS (GENETICS); SPHEROIDS, CELLULAR; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 33847194591     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp0600586     Document Type: Article

References (31)

1. Ries, L. A. G.; Harkins, D.; Krapcho, M.; Mariotto, A.; Miller, B. A.; Feuer, E. J.; Clegg, L.; Eisner, M. P.; Horner, M. J.; Howlader, N.; Hayat, M.; Hankey, B. F.; Edwards, B. K. SEER Cancer Statistics Review, 1975-2003; National Cancer Institute: Bethesda, MD. http://seer.cancer.gov/csr/1975_2003/, based on November 2005 SEER data submission, posted to the SEER Web site, 2006.
2. Macdonald, J. S.; Astrow, A. B. Adjuvant Therapy of Colon Cancer. Semin. Oncol. 2001, 28, 30-40.
3. Rojas-Martinez, A.; Martinez-Davila, I. A.; Hernandez-Garcia, A.; Aguilar-Cordova, E.; Barrera-Saldana, H. A. [Genetic Therapy of Cancer]. Rev. Invest. Clin. 2002, 54, 57-67.
4. Felgner, P. L.; Gadek, T. R.; Holm, M.; Roman, R.; Chan, H. W.; Wenz, M.; Northrop, J. P.; Ringold, G. M.; Danielsen, M. Lipofection: A Highly Efficient, Lipid Mediated DNA-Transfection Procedure. Proc. Natl. Acad. Sci. U.S.A. 1987, 84, 7413-7417.
5. Liu, D.; Ren, T.; Gao, X. Cationic Transfection Lipids. Curr. Med. Chem. 2003, 10, 1307-1315.
6. Erbacher, P.; Bettinger, T.; Brion, E.; Coll, J. L.; Plank, C.; Behr, J. P.; Remy, J. S. Genuine DNA/Polyethylenimine (PEI) Complexes Improve Transfection Properties and Cell Survival. J. Drug Targeting 2004, 12, 223-236.
7. Bally, M. B.; Harvie, P.; Wong, F. M.; Kong, S.; Wasan, E. K.; Reimer, D. L. Biological Barriers to Cellular Delivery of Lipid-Based DNA Carriers. Adv. Drug Delivery Rev. 1999, 38, 291-315.
8. Kircheis, R.; Wightman, L.; Wagner, E. Design and Gene Delivery Activity of Modified Polyethylenimines. Adv. Drug Delivery Rev. 2001, 53, 341-358.
9. Templeton, N. S. Cationic Liposome-Mediated Gene Delivery in Vivo. Biosci. Rep. 2002, 22, 283-295.
10. Merdan, T.; Kunath, K.; Petersen, H.; Bakowsky, U.; Voigt, K. H.; Kopecek, J.; Kissel, T. PEGylation of Poly(Ethylene Imine) Affects Stability of Complexes With Plasmid DNA Under in Vivo Conditions in a Dose-Dependent Manner After Intravenous Injection into Mice. Bioconjugate Chem. 2005, 16, 785-792.
11. Miller, N.; Whelan, J. Progress in Transcriptionally Targeted and Regulatable Vectors for Genetic Therapy. Hum. Gene Ther. 1997, 8, 803-815.
12. Nettelbeck, D. M.; Jerome, V.; Muller, R. A Strategy for Enhancing the Transcriptional Activity of Weak Cell Type-Specific Promoters. Gene Ther. 1998, 5, 1656-1664.
13. Lipinski, K. S.; Djeha, H. A.; Gawn, J.; Cliffe, S.; Maitland, N. J.; Palmer, D. H.; Mountain, A.; Irvine, A. S.; Wrighton, C. J. Optimization of a Synthetic Beta-Catenin-Dependent Promoter for Tumor-Specific Cancer Gene Therapy. Mol. Ther. 2004, 10, 150-161.
14. Kinzler, K. W.; Vogelstein, B. Lessons From Hereditary Colorectal Cancer. Cell 1996, 87, 159-170.
15. Vecsey-Semjen, B.; Becker, K. F.; Sinski, A.; Blennow, E.; Vietor, I.; Zatloukal, K.; Beug, H.; Wagner, E.; Huber, L. A. Novel Colon Cancer Cell Lines Leading to Better Understanding of the Diversity of Respective Primary Cancers. Oncogene 2002, 21, 4646-4662.
16. Pelisek, J.; Gaedtke, L.; DeRouchey, J.; Walker, G. F.; Nikol, S.; Wagner, E. Optimized Lipopolyplex Formulations for Gene Transfer to Human Colon Carcinoma Cells Under in Vitro Conditions. J. Gene Med. 2006, 8, 186-197.
17. Plank, C.; Zatloukal, K.; Cotten, M.; Mechtler, K.; Wagner, E. Gene Transfer into Hepatocytes Using Asialoglycoprotein Receptor Mediated Endocytosis of DNA Complexed With an Artificial Tetra-Antennary Galactose Ligand. Bioconjugate Chem. 1992, 3, 533-539.
18. Buschle, M.; Cotten, M.; Kirlappos, H.; Mechtler, K.; Schaffner, G.; Zauner, W.; Birnstiel, M. L.; Wagner, E. Receptor-Mediated Gene Transfer into Human T Lymphocytes Via Binding of DNA/CD3 Antibody Particles to the CD3 T Cell Receptor Complex. Hum. Gene Ther. 1995, 6, 753-761.
19. Schreiber, S.; Kampgen, E.; Wagner, E.; Pirkhammer, D.; Trcka, J.; Korschan, H.; Lindemann, A.; Dorffner, R.; Kittler, H.; Kasteliz, F.; Kupcu, Z.; Sinski, A.; Zatloukal, K.; Buschle, M.; Schmidt, W.; Birnstiel, M.; Kempe, R. E.; Voigt, T.; Weber, H. A.; Pehamberger, H.; Mertelsmann, R.; Brocker, E. B.; Wolff, K.; Stingl, G. Immunotherapy of Metastatic Malignant Melanoma by a Vaccine Consisting of Autologous Interleukin 2-Transfected Cancer Cells: Outcome of a Phase I Study. Hum. Gene Ther. 1999, 10, 983-993.
20. Lieubeau-Teillet, B.; Rak, J.; Jothy, S.; Iliopoulos, O.; Kaelin, W.; Kerbel, R. S. Von Hippel-Lindau Gene-Mediated Growth Suppression and Induction of Differentiation in Renal Cell Carcinoma Cells Grown As Multicellular Tumor Spheroids. Cancer Res. 1998, 58, 4957-4962.
21. Pelisek, J.; Engelmann, M. G.; Golda, A.; Fuchs, A.; Armeanu, S.; Shimizu, M.; Mekkaoui, C.; Rolland, P. H.; Nikol, S. Optimization of Nonviral Transfection: Variables Influencing Liposome-Mediated Gene Transfer in Proliferating Vs. Quiescent Cells in Culture and in Vivo Using a Porcine Restenosis Model. J. Mol. Med. 2002, 80, 724-736.
22. Kursa, M.; Walker, G. F.; Roessler, V.; Ogris, M.; Roedl, W.; Kircheis, R.; Wagner, E. Novel Shielded Transferrin-Polyethylene Glycol-Polyethylenimine/ DNA Complexes for Systemic Tumor-Targeted Gene Transfer. Bioconjugate Chem. 2003, 14, 222-231.
23. Ogris, M.; Carlisle, R. C.; Bettinger, T.; Seymour, L. W. Melittin Enables Efficient Vesicular Escape and Enhanced Nuclear Access of Nonviral Gene Delivery Vectors. J. Biol. Chem. 2001, 276, 47550-47555.
24. Ogris, M.; Steinlein, P.; Kursa, M.; Mechtler, K.; Kircheis, R.; Wagner, E. The Size of DNA/Transferrin-PEI Complexes Is an Important Factor for Gene Expression in Cultured Cells. Gene Ther. 1998, 5, 1425-1433.
25. Lipinski, K. S.; Djeha, A. H.; Ismail, T.; Mountain, A.; Young, L. S.; Wrighton, C. J. High-Level, Beta-Catenm/TCF-Dependent Transgene Expression in Secondary Colorectal Cancer Tissue. Mol. Ther. 2001, 4, 365-371.
26. Peifer, M. Signal Transduction. Neither Straight nor Narrow. Nature 1999, 400, 213-215.
27. Gao, X.; Huang, L. Potentiation of Cationic Liposome-Mediated Gene Delivery by Polycations. Biochemistry 1996, 35, 1027-1036.
28. Lampela, P.; Raisanen, J.; Mannisto, P. T.; Yla-Herttuala, S.; Raasmaja, A. The Use of Low-Molecular-Weight PEIs As Gene Carriers in the Monkey Fibroblastoma and Rabbit Smooth Muscle Cell Cultures. J. Gene Med. 2002, 4, 205-214.
29. Lampela, P.; Soininen, P.; Urtti, A.; Mannisto, P. T.; Raasmaja, A. Synergism in Gene Delivery by Small PEIs and Three Different Nonviral Vectors. Int. J. Pharm. 2004, 270, 175-184.
30. Walker, G. F.; Fella, C.; Pelisek, J.; Fahrmeir, J.; Boeckle, S.; Ogris, M.;Wagner, E. Toward synthetic viruses: Endosomal pH triggered deshielding of targeted polyplexes greatly enhances gene transfer in vitro and in vivo. Mol. Ther. 2005, 11, 418-425.
31. Bishop, J. S.; Thull, N. M.; Matar, M.; Quezada, A.; Munger, W. E.; Batten, T. L.; Muller, S.; Pericle, F. Antitumoral Effect of a Nonviral Interleukin-2 Gene Therapy Is Enhanced by Combination With 5-Fluorouracil. Cancer Gene Ther. 2000, 7, 1165-1171.